SS PHARMA LLC

Overview

SS PHARMA LLC is an active pharmaceutical ingredient (API) supplier with 21 active FDA Type II Drug Master Files, covering ACEBUTOLOL HYDROCHLORIDE USP; ATROPINE SULFATE MONOHYDRATE USP; CHLORZOXAZONE USP; ESTAZOLAM USP; L-GLUTAMINE USP; LEVOCARNITINE USP.

API / Drug Master Files

SS PHARMA LLC holds 21 active (21 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• RIVAROXABAN USPActive2025-09-28
• METHENAMINE HIPPURATEActive2024-07-04
• TRIHEPTANOINActive2024-02-12
• ESTAZOLAM USPActive2023-09-23
• LEVOKETOCONAZOLEActive2023-03-10
• TRIENTINE TETRAHYDROCHLORIDEActive2023-03-09
• TAFAMIDIS (CC)Active2023-02-08
• LEVOCARNITINE USPActive2022-04-07
• PRUCALOPRIDE SUCCINATEActive2022-02-18
• L-GLUTAMINE USPActive2021-08-26
• ACEBUTOLOL HYDROCHLORIDE USPActive2021-04-30
• METHSUXIMIDE USPActive2020-12-30
• TAFAMIDISActive2020-09-18
• ATROPINE SULFATE MONOHYDRATE USPActive2019-08-08
• STIRIPENTOLActive2019-03-05

Showing 15 of 21 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to SS PHARMA LLC in our records. PharmaTek screens the full directory against live FDA enforcement data.